267 related articles for article (PubMed ID: 14714568)
1. Purinergic receptor expression in the regeneration epidermis in a rat model of normal and delayed wound healing.
Greig AV; James SE; McGrouther DA; Terenghi G; Burnstock G
Exp Dermatol; 2003 Dec; 12(6):860-71. PubMed ID: 14714568
[TBL] [Abstract][Full Text] [Related]
2. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes.
Greig AV; Linge C; Terenghi G; McGrouther DA; Burnstock G
J Invest Dermatol; 2003 Jun; 120(6):1007-15. PubMed ID: 12787128
[TBL] [Abstract][Full Text] [Related]
3. Purinoceptor expression on keratinocytes reflects their function on the epidermis during chronic venous insufficiency.
Metcalfe MJ; Baker DM; Burnstock G
Arch Dermatol Res; 2006 Nov; 298(6):301-7. PubMed ID: 16967306
[TBL] [Abstract][Full Text] [Related]
4. Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis.
Greig AV; Linge C; Cambrey A; Burnstock G
J Invest Dermatol; 2003 Nov; 121(5):1145-9. PubMed ID: 14708618
[TBL] [Abstract][Full Text] [Related]
5. Characterization of multiple P2X receptors in cultured normal human epidermal keratinocytes.
Inoue K; Denda M; Tozaki H; Fujishita K; Koizumi S; Inoue K
J Invest Dermatol; 2005 Apr; 124(4):756-63. PubMed ID: 15816834
[TBL] [Abstract][Full Text] [Related]
6. Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors.
Burrell HE; Bowler WB; Gallagher JA; Sharpe GR
J Invest Dermatol; 2003 Mar; 120(3):440-7. PubMed ID: 12603858
[TBL] [Abstract][Full Text] [Related]
7. Changes in cytokeratin expression in epidermal keratinocytes during wound healing.
Watanabe S; Osumi M; Ohnishi T; Ichikawa E; Takahashi H
Histochem Cell Biol; 1995 Jun; 103(6):425-33. PubMed ID: 7584549
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of ionotropic purinergic receptors on mouse taste bud cells.
Hayato R; Ohtubo Y; Yoshii K
J Physiol; 2007 Oct; 584(Pt 2):473-88. PubMed ID: 17702819
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells.
Resende RR; Britto LR; Ulrich H
Int J Dev Neurosci; 2008 Nov; 26(7):763-77. PubMed ID: 18675894
[TBL] [Abstract][Full Text] [Related]
10. Activation of P2X(7) receptors stimulates the expression of P2Y(2) receptor mRNA in astrocytes cultured from rat brain.
D'Alimonte I; Ciccarelli R; Di Iorio P; Nargi E; Buccella S; Giuliani P; Rathbone MP; Jiang S; Caciagli F; Ballerini P
Int J Immunopathol Pharmacol; 2007; 20(2):301-16. PubMed ID: 17624242
[TBL] [Abstract][Full Text] [Related]
11. P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats.
Coutinho-Silva R; Parsons M; Robson T; Lincoln J; Burnstock G
Mol Cell Endocrinol; 2003 Jun; 204(1-2):141-54. PubMed ID: 12850289
[TBL] [Abstract][Full Text] [Related]
12. Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells.
D'Ambrosi N; Murra B; Cavaliere F; Amadio S; Bernardi G; Burnstock G; Volonté C
Neuroscience; 2001; 108(3):527-34. PubMed ID: 11738265
[TBL] [Abstract][Full Text] [Related]
13. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
[TBL] [Abstract][Full Text] [Related]
14. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
15. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
[TBL] [Abstract][Full Text] [Related]
16. Purinoceptor expression in regenerating skeletal muscle in the mdx mouse model of muscular dystrophy and in satellite cell cultures.
Ryten M; Yang SY; Dunn PM; Goldspink G; Burnstock G
FASEB J; 2004 Sep; 18(12):1404-6. PubMed ID: 15231720
[TBL] [Abstract][Full Text] [Related]
17. P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption.
Denda M; Inoue K; Fuziwara S; Denda S
J Invest Dermatol; 2002 Nov; 119(5):1034-40. PubMed ID: 12445189
[TBL] [Abstract][Full Text] [Related]
18. UV-B induced alteration in purinergic receptors and signaling on HaCaT keratinocytes.
Ruzsnavszky O; Telek A; Gönczi M; Balogh A; Remenyik E; Csernoch L
J Photochem Photobiol B; 2011 Oct; 105(1):113-8. PubMed ID: 21862341
[TBL] [Abstract][Full Text] [Related]
19. Regulation of epidermal homeostasis through P2Y2 receptors.
Dixon CJ; Bowler WB; Littlewood-Evans A; Dillon JP; Bilbe G; Sharpe GR; Gallagher JA
Br J Pharmacol; 1999 Aug; 127(7):1680-6. PubMed ID: 10455326
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in the localization of P2X (nucleotide) receptors in the rat adrenal gland.
Afework M; Burnstock G
Int J Dev Neurosci; 2000 Oct; 18(6):515-20. PubMed ID: 10884596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
